Skip to main content
Log in

Metabolite signature in acute ischemic stroke thrombi: a systematic review

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Metabolites are reliable biomarkers for many diseases. However, their role in acute ischemic stroke (AIS) pathogenesis is not well understood. In this systematic review we aim to evaluate the current literature on the presence of metabolites in thrombi retrieved by mechanical thrombectomy from AIS patients. Following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 guidelines, we searched OVID Medline, PubMed, OVID Embase, Scopus, and Web of Science until July 13, 2022. Metabolites lists were extracted, and pathway analysis was performed in MetaboAnalyst database. Four articles listing metabolites were included in this systematic review. D-Glucose, diacylglycerol, phytosphingosine, galabiosylceramide, glucosylceramide and 4-hydroxynonenal were reported to be associated with clots. Metabolomics data analysis showed that glycolysis, lactose, and sphingolipid metabolism pathways were enriched. In conclusion, results of the present study show that the thrombi niche has a glycolytic phenotype. Future studies should work to better understand the metabolic properties of AIS thrombi.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Deng W, Beecher C, Burant C, De Jong F, Lopez M, Wickham T, Elia M, Feeney K, McMullin D, Buonanno F, Lo E, Ning M (2015) Metabolomic analysis reveals novel small molecule plasma markers of hyperacute ischemic stroke (S30.001). 84:S30001

  2. Montaner J, Ramiro L, Simats A, Tiedt S, Makris K, Jickling GC, Debette S, Sanchez J-C, Bustamante A (2020) Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke. Nat Reviews Neurol 16:247–264. https://doi.org/10.1038/s41582-020-0350-6

    Article  Google Scholar 

  3. Maekawa K, Sugita C, Yamashita A, Moriguchi-Goto S, Furukoji E, Sakae T, Gi T, Hirai T, Asada Y (2019) Higher lactate and purine metabolite levels in erythrocyte-rich fresh venous thrombus: potential markers for early deep vein thrombosis. Thromb Res 177:136–144. https://doi.org/10.1016/j.thromres.2019.03.011

    Article  CAS  PubMed  Google Scholar 

  4. ESOC 2022 Abstract Book (2022) Eur Stroke J 7:3–545. https://doi.org/10.1177/23969873221087559

    Article  Google Scholar 

  5. Li W, Bai X, Hao J, Xu X, Lin F, Jiang Q, Ding C, Dai G, Peng F, Zhang M, Feng Y, Wang J, Chen X, Xue T, Guo X, Fu Z, Chen WH, Zhang L, Wang C, Jiao L (2022) Thrombosis origin identification of cardioembolism and large artery atherosclerosis by distinct metabolites. J Neurointerv Surg. 2023 Jul;15(7):701–707. Epub 2022 Jun 2. PMID: 35654581. https://doi.org/10.1136/neurintsurg-2022-019047

  6. Suissa L, Guigonis J-M, Graslin F, Doche E, Osman O, Chau Y, Sedat J, Lindenthal S, Pourcher T (2020) Metabolome of Cerebral Thrombi reveals an association between high glycemia at Stroke Onset and Good Clinical Outcome. Metabolites 10:483. https://doi.org/10.3390/metabo10120483

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Osakada Y, Yamashita T, Morihara R, Matsumoto N, Sasaki R, Tadokoro K, Nomura E, Kawahara Y, Omote Y, Hishikawa N, Takemoto M, Ohta Y, Suruga Y, Nagase T, Takasugi Y, Inoue S, Watanabe K, Deguchi K, Tokunaga K, Sasada S, Kobayashi K, Maeoka R, Fukutome K, Takahashi K, Ohnishi H, Kuga Y, Ohnishi H, Abe K (2021) 4-Hydroxyl-2-Nonenal localized expression pattern in retrieved clots is Associated with large artery atherosclerosis in Stroke Patients. J stroke Cerebrovasc diseases: official J Natl Stroke Association 30:105583. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105583

    Article  Google Scholar 

  8. Tian H-p, Qiu T-z, Zhao J, Li L-x, Guo J (2009) Sphingomyelinase-induced ceramide production stimulate calcium-independent JNK and PP2A activation following cerebral ischemia. Brain Injury 23:1073–1080. https://doi.org/10.3109/02699050903379388

    Article  PubMed  Google Scholar 

  9. Mohamud Yusuf A, Hagemann N, Hermann DM (2019) The Acid Sphingomyelinase/ Ceramide System as Target for ischemic stroke therapies. Neuro-Signals 27:32–43. https://doi.org/10.33594/000000184

    Article  PubMed  Google Scholar 

  10. Sidorov EV, Xu C, Garcia-Ramiu J, Blair A, Ortiz-Garcia J, Gordon D, Chainakul J, Sanghera DK (2022) Global metabolomic profiling reveals disrupted lipid and amino acid metabolism between the Acute and chronic stages of ischemic stroke. J Stroke Cerebrovasc Diseases: Official J Natl Stroke Association 31:106320. https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106320

    Article  Google Scholar 

  11. Sidorov EV, Rout M, Xu C, Larsen J, Fields E, Apple B, Smith K, Gordon D, Chainakul J, Sanghera D (2023) Comparison of Acute and Chronic Stage Ischemic Stroke Metabolome with Controls. Research Square https://doi.org/10.21203/rs.3.rs-2515376/v1

  12. Zhang X, Bi X (2020) Post-Stroke Cognitive Impairment: a review focusing on molecular biomarkers. J Mol neuroscience: MN 70:1244–1254. https://doi.org/10.1007/s12031-020-01533-8

    Article  CAS  Google Scholar 

  13. Gong D (2021) Plasma ceramides and acute ischemic stroke patients. J Formos Med Association = Taiwan Yi Zhi 120:1660. https://doi.org/10.1016/j.jfma.2021.03.017

    Article  Google Scholar 

  14. Peters L, Kuebler WM, Simmons S (2022) Sphingolipids in atherosclerosis: chimeras in structure and function. Int J Mol Sci 23:11948. https://doi.org/10.3390/ijms231911948

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Brouns R, Sheorajpanday R, Wauters A, De Surgeloose D, Mariën P, De Deyn PP (2008) Evaluation of lactate as a marker of metabolic stress and cause of secondary damage in acute ischemic stroke or TIA. Clin Chim Acta 397:27–31. https://doi.org/10.1016/j.cca.2008.07.016

    Article  CAS  PubMed  Google Scholar 

  16. Di Meglio L, Desilles JP, Ollivier V, Nomenjanahary MS, Di Meglio S, Deschildre C, Loyau S, Olivot JM, Blanc R, Piotin M, Bouton MC, Michel JB, Jandrot-Perrus M, Ho-Tin-Noé B, Mazighi M (2019) Acute ischemic stroke thrombi have an outer shell that impairs fibrinolysis. Neurology 93:e1686–e98. https://doi.org/10.1212/wnl.0000000000008395

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Research reported in this publication was in part supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number NS105853. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Santhosh Arul.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arul, S., Ghozy, S., Mereuta, O.M. et al. Metabolite signature in acute ischemic stroke thrombi: a systematic review. J Thromb Thrombolysis 56, 594–602 (2023). https://doi.org/10.1007/s11239-023-02869-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-023-02869-9

Keywords

Navigation